Home
>
National Drug Code (NDC)
>
Septra DS
Septra DS - 61570-053-20 - (TRIMETHOPRIM and SULFAMETHOXAZOLE)
Drug Information of Septra DS
| Product NDC: | 61570-053 |
| Proprietary Name: | Septra DS |
| Non Proprietary Name: | TRIMETHOPRIM and SULFAMETHOXAZOLE |
| Active Ingredient(s): | 800; 160 mg/1; mg/1 & nbsp; TRIMETHOPRIM and SULFAMETHOXAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Septra DS
| Product NDC: | 61570-053 |
| Labeler Name: | Monarch Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017376 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19730730 |
Package Information of Septra DS
| Package NDC: | 61570-053-20 |
| Package Description: | 20 TABLET in 1 BOTTLE (61570-053-20) |
NDC Information of Septra DS
| NDC Code | 61570-053-20 |
| Proprietary Name | Septra DS |
| Package Description | 20 TABLET in 1 BOTTLE (61570-053-20) |
| Product NDC | 61570-053 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TRIMETHOPRIM and SULFAMETHOXAZOLE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19730730 |
| Marketing Category Name | NDA |
| Labeler Name | Monarch Pharmaceuticals, Inc. |
| Substance Name | SULFAMETHOXAZOLE; TRIMETHOPRIM |
| Strength Number | 800; 160 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Sulfonamide Antimicrobial [EPC],Sulfonamides [Chemical/Ingredient] |
